January 5, 2023
Immune system B-cells can help predict HER2-positive breast cancer treatment response
Researchers report specific immune system cells can help them determine whether HER2-positive breast cancer will respond to treatment.
January 5, 2023
Researchers report specific immune system cells can help them determine whether HER2-positive breast cancer will respond to treatment.
December 9, 2022
Charles Perou, PhD, presented the 2022 AACR Distinguished Lectureship in Breast Cancer Research at the 45th San Antonio Breast Cancer Symposium.
December 7, 2022
Yara Abdou, MD, lead author of the study, presented findings at the San Antonio Breast Cancer Symposium.
December 7, 2022
December 6, 2022
UNC Lineberger researchers and colleagues will be presenting the latest findings from basic, translational and clinical studies at the 45th annual San Antonio Breast Cancer Symposium.
November 18, 2022
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2022 Highly Cited Researchers list.
September 13, 2022
Researchers developed three different computer models to predict how a hypothetical set of patients with specific types of metastatic breast cancer would respond to different sequences and types of chemotherapy.
June 17, 2022
A study by Sarah J. Nyante, PhD, MSPH, and colleagues found that the rate of diagnostic accuracy is highest in non‐Hispanic white women and lowest in Hispanic women.
December 15, 2020
Kirsten Nyrop, PhD, and colleagues found Black women with early breast cancer had higher rates of obesity and other health conditions that can affect outcomes, compared with white women.
April 21, 2020
Kirsten Nyrop, PhD, Hyman Muss, MD, and colleagues compared how women with breast cancer rated the severity of 17 of their own symptoms with physician ratings of chemotherapy toxicity.